Advertisement

Electron Paramagnetic Resonance Spin-Labeling Analysis of Synaptosomal Membrane Protein Oxidation

  • D. Allan Butterfield
Protocol
  • 535 Downloads
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

Synaptosomal protein oxidation, most often indexed by increased protein carbonyl content (1,2), is one biomarker of oxidative stress in brain (2). Protein carbonyls are detected by UV-Vis spectrometric, fluorescence, or immunochemical methods (2), and are increased in a variety of oxidative stress disorders of the brain. Among the latter are Alzheimer’s disease (AD) (3) and animal models of AD (4), Huntington’s disease (HD) (5,6), and accelerated aging (7).

Keywords

Electron Paramagnetic Resonance Electron Paramagnetic Resonance Spectrum Glutamine Synthetase Spin Label Electron Paramagnetic Resonance Spectrometer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220–1224.PubMedCrossRefGoogle Scholar
  2. 2.
    Butterfield, D. A. and Stadtman, E. R. (1997) Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2, 161–191.CrossRefGoogle Scholar
  3. 3.
    Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., et al. (1995) Brain regional correspondence between Alzheimer’s disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146–2156.PubMedCrossRefGoogle Scholar
  4. 4.
    Yatin, S. M., Link, C. D., and Butterfield, D. A. (1999) In-vitro and in-vivo oxidative stress associated with Alzheimer’s amyloid β-peptide (1–42). Neurobiol. Aging 20, 325–330.PubMedCrossRefGoogle Scholar
  5. 5.
    La Fontaine, M. A., Geddes, J. W., Banks, A., and Butterfield, D. A. (2000) 3-Nitropropionic acid induced in-vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington’s disease. Brain Research 858, 356–362.PubMedCrossRefGoogle Scholar
  6. 6.
    La Fontaine, M. A., Geddes, J. W., Banks, A., and Butterfield, D. A. (2000) Effect of exogenous and endogenous antioxidants on 3-nitropropionic acidinduced in-vivo oxidative stress and striatal lesions: insights into Huntington’s disease. J. Neurochem. 75, 1709–1715.PubMedCrossRefGoogle Scholar
  7. 7.
    Butterfield, D. A., Howard, B. J., Yatin, S., Allen, K. L., and Carney, J. M. (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. USA 94, 674–678.PubMedCrossRefGoogle Scholar
  8. 8.
    Butterfield, D. A. (1982) Spin labeling in disease. Biol. Mag. Reson. 4, 1–78.Google Scholar
  9. 9.
    McConnell, H. M. and McFarland, B. G. (1970) Physics and chemistry of spin labels. Q. Rev. Biophys. 3, 91–136.PubMedCrossRefGoogle Scholar
  10. 10.
    Hensley, K., Carney, J., Hall, N., Shaw, W., and Butterfield, D. A. (1994) Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radic. Biol. Med. 17, 321–331.PubMedCrossRefGoogle Scholar
  11. 11.
    Umhauer, S. A., Isbell, D. T., and Butterfield, D. A. (1992) Spin labeling of membrane proteins in mammalian brain synaptic plasma membranes: partial characterization. Anal. Lett. 25, 1201–1215.Google Scholar
  12. 12.
    Matsumoto, N., Shiomura, T., Ishihara, T., Adachi, H., and Miwa, S. (1976) Extraction of erythrocyte membrane proteins by sulfhydryl inhibitors. Tohoku J. Exp. Med. 120, 365–376.PubMedCrossRefGoogle Scholar
  13. 13.
    Lauderback, C. M., Hackett, J. M., Keller, J. N., Varadarajan, S., Sweda, L., Kindy, M., et al. (2001) Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by Aβ(1–40): Implications for Alzheimer’s disease. Biochemistry 40, 2548–2554.PubMedCrossRefGoogle Scholar
  14. 14.
    Pocernich, C. B., La Fontaine, M., and Butterfield, D. A. (2000) In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem. Int. 36, 185–191.PubMedCrossRefGoogle Scholar
  15. 15.
    Subramaniam, R., Koppal, T., Green, M., Yatin, S., Jordan, B., and Butterfield, D.A. (1998) The free radical antioxidant vitamin E protects cortical synaptosomal membrane proteins from amyloid β-peptide (25–35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer’s disease. Neurochem. Res. 23, 1403–1410.PubMedCrossRefGoogle Scholar
  16. 16.
    Hall, N. C., Carney, J. M., Cheng, M. S., and Butterfield, D. A. (1995) Ischemia/reperfusion induced changes in membrane proteins and lipids of gerbil cortical synaptosomes. Neuroscience 64, 81–89.PubMedCrossRefGoogle Scholar
  17. 17.
    Hall, N. C., Carney, J. M., Cheng, M., and Butterfield, D. A. (1995) Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-α-phenylnitrone and difluoromethylornithine. Neuroscience 69, 591–600.PubMedCrossRefGoogle Scholar
  18. 18.
    Hall, N. C., Dempsey, R. J., Carney, J. M., Donaldson, D. L., and Butterfield, D. A. (1995) Structural alterations in synaptosomal membrane-associated proteins and lipids by transient middle cerebral artery occulusion in the cat. Neurochem. Res. 20, 1161–1169.PubMedCrossRefGoogle Scholar
  19. 19.
    Hall, N. C., Carney, J. M., Plante, O. J., Cheng, M., and Butterfield, D. A. (1997) Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids. Neuroscience 77, 283–290.PubMedCrossRefGoogle Scholar
  20. 20.
    Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., and Butterfield, D. A. (1997) The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem. 69, 1161–1169.PubMedCrossRefGoogle Scholar
  21. 21.
    Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., and Butterfield, D. A. (2001) Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 39, 141–149.PubMedCrossRefGoogle Scholar
  22. 22.
    Koppal, T., Drake, J., Yatin, S., Jordan, B., Varadarajan, S., Bettenhausen, L., and Butterfield, D. A. (1999) Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer’s disease. J. Neurochem. 72, 310–317.PubMedCrossRefGoogle Scholar
  23. 23.
    Koppal, T., Drake, J., and Butterfield, D. A. (1999) In-vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage. Biochim. Biophys. Acta 1453, 407–411.PubMedGoogle Scholar
  24. 24.
    Howard, B. J., Yatin, S., Hensley, K., Allen, K. L., Kelly, J. P., Carney, J., and Butterfield, D. A. (1996) Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-Tert-Butyl-α-phenylnitrone (PBN) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol). J. Neurochem. 67, 2045–2050.PubMedCrossRefGoogle Scholar
  25. 25.
    Butterfield, D. A., Hensley, K., Cole, P., Subramaniam, R., Aksenov, M., Aksenova, M., et al. (1997) Oxidatively-induced structural alteration of glutamine synthetase assessed by analysis of spin labeled incorporation kinetics: relevance to Alzheimer’s disease. J. Neurochem. 68, 2451–2457.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc.,Totowa, NJ 2003

Authors and Affiliations

  • D. Allan Butterfield
    • 1
  1. 1.Sanders-Brown Center on Aging Center of Membrane Sciences Department of ChemistryUniversity of KentuckyLexington

Personalised recommendations